Immunology Weekly News - October 8th 2025
October 8, 2025ACLF,tulisokibart,leo pharma,spesolimab,merck,Spevigo,Celltrion,roflumilast,BioPharma and Tech News,tocilizumab biosim,melanoma,Immunology News,Evommune,Onco3R Therapeutics,SIK3 Inhibitor,IO Biotech,Organoids,Regulatory T cells,ArcutisFOXP3,UTOpia bioartificial liver
🧬 This Week in Immunology: robotic ESD milestone, pediatric AD access, in vivo…
Neuroscience Weekly News - October 8th 2025
October 8, 2025Neurodegenerative disorders,Precision neurology,clinical trials,Neuroscience News,multiple sclerosis,Alzheimer's Disease,BioPharma and Tech News,BTK Inhibitors,Neuromodulation,Ocrelizumab,Pediatric-onset MS,Fingolimod,Remyelination,RNAi therapeutics,Blood–brain barrierMigraine therapy,Biomarkers
🧠 This Week in Neuroscience: China’s Nerivio Nod, Ocrevus in Pediatric MS,…
ESGCT 2025 Preview: Key Gene & Cell Therapy Highlights to Watch
October 7, 2025Our Insights,crisprAAV,gene therapy,Cell Therapy,CAR T,Conference Previews,ESGCT 2025,LNP,HSC,non-viral delivery,oncolytic virus
ESGCT 2025 at a glance Ahead of ESGCT 2025, LucidQuest outlines the…
Latest Endocrinology News - Sept 24th to Oct 7th 2025
October 7, 2025Endocrinology News,sanofiCelltrion,BioPharma and Tech News,Acromegaly,EASD,Denosumab,AVT03,Prolia,Xgeva,Paltusotine,Crinetics,Hypothyroidism,Diabetes distress,Revvity
Watch Our Video Summary Capturing Top Endocrinology News from the Last Two…
Endocrinology Weekly Update - October 7th 2025
October 7, 2025Biopharmaceuticals,Endocrinology News,clinical trials,precision medicine,BioPharma and Tech News,Tirzepatide,osteoporosis,type 1 diabetes,Health Canada,Cushing’s disease,Hypothyroidism,Autoantibodies,ACTH-dependent Cushing’s,OsilodrostatYAP signaling,Hippo pathway
Endocrinology Update: Isturisa dosing model, YAP–T1D link, Mounjaro expansion…
Obesity Weekly News - October 7th 2025
October 7, 2025out-of-pocket obesity market,metabolic disease innovation,semaglutide,Obesity News,BioPharma and Tech News,Tirzepatide,GLP-1 Receptor Agonists,Metsera,Efsubaglutide Alfa,Hanmi HM17321,Endevica 710GO,Ildong oral GLP-1,IQVIA access strategy,EASO obesity guideline,Nanologica NLAB Sagaobesity therapeutics,digital obesity care
Obesity Update: MET-097i Breakthrough, New EASO Guidelines, & More! From…
Latest Artificial Intelligence and Digital Health News - Sept 23rd to Oct 6th 2025
October 6, 2025AI in Healthcare and Digital Health,GoogleBioPharma and Tech News,NICE,Microsoft,NHS,Eric Horvitz,DNA screening,biosecurity,SenseTime,IHH Healthcare,lung cancer screening,Alphabet,Verily,QuantHealth
Watch Our Video Summary Capturing Top AI in Healthcare and Digital Health News…
Artificial Intelligence and Digital Health Weekly News - October 6th 2025
October 6, 2025Parkway Radiology,Microsoft biosecurity,HealthTech,AI in Healthcare and Digital Health,BioPharma and Tech News,HEART FAILURE,Glioblastoma,NICE,NHS,Sanofi Ventures,SenseTime,IHH Healthcare,Verily,QuantHealth,SleepSpacePCNSL,digital twin
AI in Healthcare and Digital Health Update: NICE reforms, AI weight-loss gains,…
Latest Hematology News - Sept 22nd to Oct 6th 2025
October 6, 2025Valoctocogene Roxaparvovec,Pivekimab Sunirine,abbvie,Mim8,CRISPR Therapeutics,Acute Myeloid Leukemia,Multiple Myeloma,Paroxysmal Nocturnal Hemoglobinuria,Hemophilia A,Hematology News,BioPharma and Tech News,Ziftomenib,Novo Nordisk,Tuspetinib,Hanmi Pharmaceutical,Kyowa Kirin,Heidelberg Pharma,HDP-101Kura Oncology,Aptose Biosciences
Watch Our Video Summary Capturing Top Hematology News from the Last Two Weeks…
Hematology Weekly News - October 6th 2025
October 6, 2025cutaneous T-cell lymphoma,Umoja Biopharma,abbvie,Hematology News,pfizer,Multiple Myeloma,Sickle Cell Disease,Hemophilia A,BioPharma and Tech News,AML,CAR T Therapy,follicular lymphoma,Kyowa Kirin,Kura Oncology,C4 TherapeuticsVerismo Therapeutics,Soligenix
Hematology Update: Cemsidomide–Elranatamab Combo, Ziftomenib AML Trial, Fast…
Oncology Weekly News - October 6th 2025
October 6, 2025UroGen,docetaxel,astrazeneca,Oncology News,roche,BioPharma and Tech News,KRAS,ENHERTU,Nuvation Bio,taletrectinib,Daiichi Sankyo,Tecentriq,lurbinectedin,Ensem Therapeutics,PI3KαCellectar,iopofosine I-131
Oncology Update: Enhertu Superiority, Tecentriq Combo Approval, New Trials…
UEG Week Preview: Key Gastroenterology Highlights to Watch
October 4, 2025Our Insights,Colorectal CancerUlcerative Colitis,Crohns Disease,Gastroenterology,Conference Previews,UEG Week 2025,celiac disease,esophagus,Helicobacter pylori,endoscopy,AI in gastroenterology
UEG Week at a Glance Get ready for UEG Week 2025. LucidQuest brings you the key…








